Homepage / English / Scientific productions / Project funding

PRINCIPAL INVESTIGATOR

• 1997

European School of Haematology

Funding of the participation to the INSERM n°89 workshop

• 1999

French research and technology ministry

Fellowship for the third year of PhD

1 year of thesis (salaries)

• 2009

German foundation for the heart (Deutsche Herzstiftung)

Study on the effects of Trypanosoma cruzi and its glycosylphosphatidylinositols on cardiomyocyte apoptosis and STAT activation

59 000 euros (salaries for 10 months + consumables)

• 2010

National Institute for Agronomic Research (INRA)

Study of the ffects of glycosylphosphatidylinositols of Neospora caninum

10 000 euros (consumables)

• 2011

Region Centre Val de Loire

Design, synthesis and evaluation of new therapeutic anti-apicomplexan imidazoazines

3 years of thesis (2012-15) (salaries)

• 2014

Region Centre Val de Loire

Development of an innovative vaccine against neosporosis combining GPIs as adjuvant and all antigens of the disease agent in a nanoparticulate platform

3 years of thesis (2015-18) (salaries)

Campus France - PHC Procope

Study of the effects of glycosylphosphatidylinositols of Neospora caninum in order to use them as adjuvant in a vaccine strategy

8 700 euros (mobility to Germany 2014-17)

• 2016

British Society for Antimicrobial Chemotherapy

Treatment of mice with imidazo[1,2-b]pyridazines targeting Toxoplasma gondii Calcium-Dependent Protein Kinase 1 to protect against congenital toxoplasmosis

19 000 euros (15 000 pounds) (consumables)

• 2017

Research Federation in Infectiology (FéRI) - Region Centre Val de Loire

Design of an innovative vaccine against neosporosis combining GPIs as adjuvant and all antigenes of the disease agent in a nanoparticulate platform

1 000 euros (mobility to Germany of the PhD student)

• 2020

Campus France - PHC Procope

Study of NETosis induced by protozoan parasites and their glycosylphosphatidylinositols on neutrophils from different animal species

6 000 euros (mobility to Germany in 2020 and 2021)

ASSOCIATED INVESTIGATOR

• 2003

German Foundation for Research (Deutsche Forschungsgemeinschaft)

Influence of glycosylphosphatidylinositols and sphingolipids from Toxoplasma gondii on the production of cytokines and the activation of Toll-like Receptors

150 000 euros (salaries for 2 years + consumables)

• 2004

German Academic Exchange Service (DAAD)

Role of Toll-like Receptors on activation of dendritic cells and macrophages by highly purified and synthetic glycosylphosphatidylinositol anchors from Toxoplasma gondii

10 000 euros (mobility to Brazil 2004-05)

• 2005

German Foundation for Research

Comparison of biological functions of glycosylphosphatidylinositols from a virulent and a non virulent strain of Toxoplasma gondii

200 000 euros (salaries for 2 years + consumables)

• 2007

German Foundation for Research

Identification of human immune receptors and associated molecules for glycosylphosphatidylinositols of Toxoplasma gondii

200 000 euros (salaries for 2 years + consumables)

• 2010

Federal Institute of Research 136 - Communicable Agents and Infectiology

Development of new therapeutic strategies to treat toxoplasmosis and cryptosporidiosis through synthesis and evaluation of polysubstituted imidazoheteroaryls

5 000 euros (consumables)

Campus France - PHC Procope

Analysis of glycoconjugates of Babesia

12 000 euros (mobility to Germany 2010-13)

• 2012

Research Federation in Infectiology (FéRI) - Region Centre Val de Loire

Development of new strategies to design anti-apicomplexan pharmacological therapeutics

10 000 euros (consumables)

• 2017

Vaxinano

Development of a vaccine against murine endogenous and exogenous congenital neosporosis

24 000 euros (consumables)

Research Federation in Infectiology (FérI) - Region Centre Val de Loire

Identification of ion channels, targets of antiparasitic treatments, in the human parasite Pediculus humanus

3 500 euros (6 months grant for a master 2 student)

• 2019

Research Federation in Infectiology (FéRI) - Region Centre Val de Loire

Characterization of ligand-gated ion channels of the human louse (Pediculus humanus) to develop new treatment strategies

10 000 euros (consumables)

• 2020

Vaxinano

In vivo study of the immune response induced by a nanoparticulate vaccine against Neospora caninum

26 000 euros (consumables)